The global phototherapy market size was valued at USD 684.43 Million in 2024 and is expected to reach USD 1,042.45 Million by 2032, at a CAGR of 5.40% during the forecast period
The market growth is largely fueled by the increasing prevalence of neonatal jaundice, psoriasis, and other skin conditions, as well as rising awareness of non-invasive treatment options. Technological progress in light-based therapies, including advancements in LED and fiber-optic systems, is enhancing treatment precision and efficacy, thereby driving adoption across healthcare facilities
Furthermore, growing consumer demand for safe, convenient, and home-based phototherapy solutions—particularly for conditions such as vitiligo, acne, and eczema—is establishing phototherapy as a preferred, patient-friendly therapeutic approach. These converging factors are accelerating the uptake of phototherapy devices, thereby significantly boosting the industry's growth